Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China · Delayed Price · Currency is CNY 4.460
-0.540 (-10.80%)
Jun 10, 2026, 11:20 AM CST
SHE:300039 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 259.16 | 278.58 | 375.58 | 327.87 | 190.8 | 140.11 |
Depreciation & Amortization | 33.49 | 33.49 | 36.05 | 37.53 | 31.71 | 33.86 |
Other Amortization | 2.19 | 2.19 | 0.29 | 0.11 | 0.01 | - |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | 0.26 | 0.21 | 0.17 | 0.22 |
Asset Writedown & Restructuring Costs | 8.82 | 8.82 | -3.03 | 7.33 | 0.65 | -6.16 |
Loss (Gain) From Sale of Investments | -18.86 | -18.86 | -11.43 | -4.92 | 10.69 | 4.85 |
Other Operating Activities | -21.92 | -0.31 | -0.43 | -1.64 | -0.44 | -0.68 |
Change in Accounts Receivable | 23.4 | 23.4 | -0.14 | 99.53 | 58.32 | -74.9 |
Change in Inventory | -12.73 | -12.73 | -16.26 | -10.33 | 4.06 | 27.22 |
Change in Accounts Payable | -84.92 | -84.92 | -102.8 | -60.18 | 76.9 | -4.37 |
Change in Other Net Operating Assets | -1.62 | -1.62 | -4.32 | -5.33 | 6.8 | 3.33 |
Operating Cash Flow | 189.7 | 230.74 | 278.95 | 382.66 | 376.42 | 126.08 |
Operating Cash Flow Growth | -35.64% | -17.28% | -27.10% | 1.66% | 198.56% | -49.70% |
Capital Expenditures | -23.46 | -27.04 | -140.52 | -29.08 | -31.62 | -42.55 |
Sale of Property, Plant & Equipment | 0.52 | 0.51 | 0.03 | 0.03 | 0.27 | 0.15 |
Cash Acquisitions | - | - | - | - | - | -14.52 |
Investment in Securities | -6.87 | 227.87 | 90.73 | -181.21 | -257.11 | -29.93 |
Other Investing Activities | 75.67 | 90.2 | 16.33 | 11.63 | 3.08 | 3.34 |
Investing Cash Flow | 45.86 | 291.54 | -33.43 | -198.63 | -285.37 | -83.51 |
Short-Term Debt Issued | - | 1.32 | 5.42 | - | - | - |
Total Debt Issued | 1.32 | 1.32 | 5.42 | - | - | - |
Short-Term Debt Repaid | - | -0.24 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | - | - | -37.72 |
Total Debt Repaid | -0.24 | -0.24 | - | - | - | -37.72 |
Net Debt Issued (Repaid) | 1.09 | 1.09 | 5.42 | - | - | -37.72 |
Common Dividends Paid | -136.03 | -136.03 | -104.6 | -62.76 | -52.3 | -31.64 |
Other Financing Activities | 0.02 | - | -0.05 | - | - | - |
Financing Cash Flow | -134.92 | -134.95 | -99.23 | -62.76 | -52.3 | -69.37 |
Net Cash Flow | 100.64 | 387.34 | 146.3 | 121.27 | 38.75 | -26.8 |
Free Cash Flow | 166.25 | 203.7 | 138.43 | 353.59 | 344.8 | 83.53 |
Free Cash Flow Growth | 11.03% | 47.16% | -60.85% | 2.55% | 312.79% | -64.71% |
Free Cash Flow Margin | 16.06% | 17.67% | 9.40% | 22.18% | 30.82% | 7.59% |
Free Cash Flow Per Share | 0.16 | 0.20 | 0.13 | 0.34 | 0.33 | 0.08 |
Cash Interest Paid | - | - | 0.04 | - | - | - |
Cash Income Tax Paid | 164.31 | 192.56 | 239.25 | 255.43 | 144.47 | 157.16 |
Levered Free Cash Flow | 122.56 | 180.94 | 15.48 | 261.78 | 275.04 | 16.78 |
Unlevered Free Cash Flow | 122.63 | 181 | 15.5 | 261.78 | 275.04 | 16.88 |
Change in Working Capital | -73.14 | -73.14 | -118.33 | 16.17 | 142.82 | -46.13 |